RANDOMIZED CONTROLLED A PILOT CLINICAL STUDY TO EVALUATE THE EFFICACY OF MEHA-MUDGARA RASA IN THE MANAGEMENT OF MADHUMEHJANYA NADIPRATHAN SHOTHA W.R.T. DIABETIC NEUROPATHY
*Dr. Ashish Hasuram Mhatre, M.D
Aim and Objectives: To evaluate clinical Efficacy of Meha-Mudgara Rasa in the management of Madhumehajanya Nadipratan Shotha w.r.t Diabetes Neuropathy. Methodology: The 40 subjects were enrolled randomly in two groups, Group A (Meha Mudagara Rasa) & Group B (Pregabalin 75 mg) for the duration of 1 month. Meha-Mudgara Rasa contains Rasanjana, Bida Lavana, Devdar, Bilvaphala, Gokshurbeeja, Dadim, Bhunimba, Pippalimula, Trikatu, Triphala, Trivrita, Lohabhasma, Shudha Guggulu & Go-Ghrita. Pregabalin is described chemically as (S) -3-(aminomethyl)-5-methylnexanoic acid, indicated in the Management of neuropathic pain associated with diabetic peripheral neuropathy. Conclusion: Results obtained with respect to the parameter burning sensation, Tingling sensation, numbness, weakness & Neuropathy Disability Score had shown statistically significant improvement. Meha-Mudgara Rasa presents window of opportunity in the clinical management of Diabetic Neuropathy.
Keywords: Diabetic Neuropathy, Meha-Mudgara Rasa, Pregabalin.
[Full Text Article]